User profiles for Bruce G. Pollock
 | Bruce G.PollockProfessor of Psychiatry and Pharmacology, Unitvrsity of Toronto Verified email at camh.ca Cited by 36403 |
Mood disorders in the medically ill: scientific review and recommendations
…, D Musselman, C O'Connor, JM Petitto, BG Pollock… - Biological …, 2005 - Elsevier
OBJECTIVE: The purpose of this review is to assess the relationship between mood disorders
and development, course, and associated morbidity and mortality of selected medical …
and development, course, and associated morbidity and mortality of selected medical …
Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years
…, PR Houck, MA Dew, JA Stack, BG Pollock… - Jama, 1999 - jamanetwork.com
ContextElderly patients with major depression are at high risk for recurrence, increased
mortality, and chronic disability.ObjectiveTo determine the efficacy of maintenance nortriptyline …
mortality, and chronic disability.ObjectiveTo determine the efficacy of maintenance nortriptyline …
Anticipating and mitigating the impact of the COVID-19 pandemic on Alzheimer's disease and related dementias
The COVID-19 pandemic is causing global morbidity and mortality, straining health systems,
and disrupting society, putting individuals with Alzheimer's disease and related dementias (…
and disrupting society, putting individuals with Alzheimer's disease and related dementias (…
The anticholinergic drug scale as a measure of drug‐related anticholinergic burden: associations with serum anticholinergic activity
…, BC Lund, PJ Perry, BG Pollock… - The Journal of …, 2006 - Wiley Online Library
Anticholinergic Drug Scale (ADS) scores were previously associated with serum anticholinergic
activity (SAA) in a pilot study. To replicate these results, the association between ADS …
activity (SAA) in a pilot study. To replicate these results, the association between ADS …
The nature and determinants of neuropsychological functioning in late-lifedepression
…, R Bhalla, CC Meltzer, BG Pollock… - Archives of general …, 2004 - jamanetwork.com
… After verifying that there were no interactions betweengroup and CIRS-G total score, we
used multivariate analysis of covariance(MANCOVA) to model the main effect of group on the 5 …
used multivariate analysis of covariance(MANCOVA) to model the main effect of group on the 5 …
Serotonin in aging, late-life depression, and Alzheimer's disease: the emerging role of functional imaging
Serotonin (5-HT) neuron and neurotransmitter loss in normal aging and neuropsychiatric
diseases of late life may contribute to behavioral changes commonly observed in the elderly …
diseases of late life may contribute to behavioral changes commonly observed in the elderly …
Depression and Bipolar Support Alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life
…, J Pearson, T Persky, BG Pollock… - Archives of general …, 2003 - jamanetwork.com
Objectives To review progress made during the past decade in late-life mood disorders and
to identify areas of unmet need in health care delivery and research. Participants The …
to identify areas of unmet need in health care delivery and research. Participants The …
Anticholinergic activity of 107 medications commonly used by older adults
ML Chew, BH Mulsant, BG Pollock… - Journal of the …, 2008 - Wiley Online Library
The objective of this study was to measure the anticholinergic activity (AA) of medications
commonly used by older adults. A radioreceptor assay was used to investigate the AA of 107 …
commonly used by older adults. A radioreceptor assay was used to investigate the AA of 107 …
Newer antidepressants and the cytochrome P450 system.
Objective This review evaluates the in vitro and in vivo evidence for inhibition of cytochrome
P450 enzymes by the newer antidepressants and provides clinical recommendations for …
P450 enzymes by the newer antidepressants and provides clinical recommendations for …
Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial
Importance Agitation is common, persistent, and associated with adverse consequences for
patients with Alzheimer disease. Pharmacological treatment options, including …
patients with Alzheimer disease. Pharmacological treatment options, including …